Sterneck M, Fischer L, Buggisch P, Malago M, Rogiers X, Burdelski M, Greten H, Broelsch C E
Department of Medicine, University Hospital Eppendorf, Hamburg.
Z Gastroenterol. 1996 Dec;34(12):795-800.
Fulminant hepatic failure is associated with considerable mortality under conservative management. The aim of this study was to assess applicability and outcome of liver transplantation using cadaveric and living donated grafts in patients with fulminant hepatic failure. 42 patients presenting with fulminant hepatic failure between 1988 and 1995 were retrospectively analyzed. 37 (88%) met the indication criteria for liver transplantation. 22 patients underwent orthotopic liver transplantation, one patient auxiliary orthotopic liver transplantation. Actual survival rate of these patients is 74% alter a mean follow-up of 23 (3-68) months. 38% (14/37) of the patients with an indication for transplantation did not receive a cadaveric graft due to scarcity of cadaveric organs (n = 9), medical contraindications (n = 3) or spontaneous recuperation (n = 2). Only 21% (3/14) of these patients survived. Due to unavailability of a cadaveric organ four patients, six months to 22 years of age, underwent living related liver transplantation as a last possible treatment option. Three of them died from cerebral herniation. It is concluded that transplantation of a cadaveric graft increased survival rate from 21% to 74% in patients with an indication for liver transplantation. Living related liver transplantation as an individual rescue therapy had no favourable outcome.
暴发性肝衰竭在保守治疗下死亡率相当高。本研究的目的是评估在暴发性肝衰竭患者中使用尸体供肝和活体供肝进行肝移植的适用性和结果。对1988年至1995年间出现暴发性肝衰竭的42例患者进行了回顾性分析。37例(88%)符合肝移植指征标准。22例患者接受了原位肝移植,1例患者接受了辅助原位肝移植。这些患者在平均随访23(3 - 68)个月后的实际生存率为74%。38%(14/37)有移植指征的患者由于尸体器官短缺(n = 9)、医学禁忌证(n = 3)或自发恢复(n = 2)而未接受尸体供肝。这些患者中只有21%(3/14)存活。由于无法获得尸体器官,4例年龄在6个月至22岁之间的患者作为最后的可能治疗选择接受了活体亲属肝移植。其中3例死于脑疝。得出的结论是,对于有肝移植指征的患者,尸体供肝移植将生存率从21%提高到了74%。活体亲属肝移植作为一种个体化的挽救治疗方法没有良好的结果。